Advancing Frontiers in Myeloproliferative Neoplasms

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding of myeloproliferative neoplasms (MPN). Breakthroughs in novel therapies, disease biology, and molecular risk stratification highlighted EHA 2025 Congress as a key event shaping the future of MPN care. Herein are the main takeaways from pivotal presentations.

Authors

Erika Morsia (ORCID: https://orcid.org/0000-0003-4453-6985)

Institutions

Marche Polytechnic University (IT)

Publication Details

Journal: EMJ Hematology
Published: 2025-07-24
DOI: https://doi.org/10.33590/emjhematol/mjud9157
Primary Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Advancing Frontiers in Myeloproliferative Neoplasms

Erika Morsia

Jul 24, 2025

EMJ Hematology

Myeloproliferative Neoplasms: Diagnosis and Treatment

article

Advancing Frontiers in Myeloproliferative Neoplasms

Erika Morsia

July 24, 2025article en

Abstract

EMJ Hematology

Marche Polytechnic University (IT)

Openalex Percentile: Top 75%

Myeloproliferative Neoplasms: Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advancing Frontiers in Myeloproliferative Neoplasms — Erika Morsia · EMJ Hematology (2025) | TGRS Research Map | TGRS